Shiqi Hui, Jing Xie, Li Dong, Li Wei, Weiwei Dai, Dongmei Li
{"title":"Deep learning-based mobile application for efficient eyelid tumor recognition in clinical images","authors":"Shiqi Hui, Jing Xie, Li Dong, Li Wei, Weiwei Dai, Dongmei Li","doi":"10.1038/s41746-025-01539-9","DOIUrl":null,"url":null,"abstract":"<p>Early detection, regular monitoring of eyelid tumors and post-surgery recurrence monitoring are crucial for patients. However, frequent hospital visits are burdensome for patients with poor medical conditions. This study validates a novel deep learning-based mobile application, based on YOLOv5 and Efficient-Net v2-B architectures, for self-diagnosing eyelid tumors, enabling improved health support systems for such patients. 1195 preprocessed clinical ocular photographs and biopsy results were collected for model training. The best-performing model was chosen and converted into a smartphone-based application, then further evaluated based on external validation dataset, achieved 0.921 accuracy for triple classification outcomes (benign/malignant eyelid tumors or normal eye), generally superior to that of general physicians, resident doctors, and ophthalmology specialists. Intelligent Eyelid Tumor Screening application exhibited a straightforward detection process, user-friendly interface and treatment recommendation scheme, provides preliminary evidence for recognizing eyelid tumors and could be used by healthcare professionals, patients and caregivers for detection and monitoring purposes.</p>","PeriodicalId":19349,"journal":{"name":"NPJ Digital Medicine","volume":"236 1","pages":""},"PeriodicalIF":12.4000,"publicationDate":"2025-03-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"NPJ Digital Medicine","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1038/s41746-025-01539-9","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"HEALTH CARE SCIENCES & SERVICES","Score":null,"Total":0}
引用次数: 0
Abstract
Early detection, regular monitoring of eyelid tumors and post-surgery recurrence monitoring are crucial for patients. However, frequent hospital visits are burdensome for patients with poor medical conditions. This study validates a novel deep learning-based mobile application, based on YOLOv5 and Efficient-Net v2-B architectures, for self-diagnosing eyelid tumors, enabling improved health support systems for such patients. 1195 preprocessed clinical ocular photographs and biopsy results were collected for model training. The best-performing model was chosen and converted into a smartphone-based application, then further evaluated based on external validation dataset, achieved 0.921 accuracy for triple classification outcomes (benign/malignant eyelid tumors or normal eye), generally superior to that of general physicians, resident doctors, and ophthalmology specialists. Intelligent Eyelid Tumor Screening application exhibited a straightforward detection process, user-friendly interface and treatment recommendation scheme, provides preliminary evidence for recognizing eyelid tumors and could be used by healthcare professionals, patients and caregivers for detection and monitoring purposes.
期刊介绍:
npj Digital Medicine is an online open-access journal that focuses on publishing peer-reviewed research in the field of digital medicine. The journal covers various aspects of digital medicine, including the application and implementation of digital and mobile technologies in clinical settings, virtual healthcare, and the use of artificial intelligence and informatics.
The primary goal of the journal is to support innovation and the advancement of healthcare through the integration of new digital and mobile technologies. When determining if a manuscript is suitable for publication, the journal considers four important criteria: novelty, clinical relevance, scientific rigor, and digital innovation.